Skip to main content

Life Sciences

By Anthony Vecchione | 02:36 pm | November 06, 2024
The aim of the alliance is to collect insights on patient outcomes and drug effectiveness with the Dario Connect platform.  
By Anthony Vecchione | 01:03 pm | November 06, 2024
The funding will support clinical trials for the company's NeuroHawk brain-scanning device.  
By Anthony Vecchione | 02:23 pm | November 05, 2024
The acquisition includes Jack's Canadian clinical assets, the authority to operate 16 medical clinics across 13 Canadian cities and the rights to operate clinics in Walmart stores in Canada.  
By Jessica Hagen | 02:32 pm | November 04, 2024
The CRISPR therapy, HG202, was conceived using AI and machine learning and aims to treat individuals with neovascular age-related macular degeneration.
By Anthony Vecchione | 03:16 pm | November 01, 2024
MedAware's AI-enabled platform allows pharmacists and clinical care personnel to intervene with medication dosages and therapy changes before potential harm occurs.
By Anthony Vecchione | 03:14 pm | October 31, 2024
Physicians will have the ability to compare medication prices in real-time and prescribe using eNavvi's platform.  
By Anthony Vecchione | 03:48 pm | October 30, 2024
ProPhet's aim is to bring down the time and cost of finding molecules for new drug targets.  
By Jessica Hagen | 11:34 am | October 29, 2024
Cuban told MobiHealthNews that he advocates for Harris because she announced she would take on non-pass-through PBMs and introduce drug transparency.
By Anthony Vecchione | 06:12 pm | October 28, 2024
The partnership aims to increase health practitioners' capabilities to master 10 essential cardiac views.  
By Anthony Vecchione | 02:45 pm | October 25, 2024
The alliance aims to improve the possibility of long-term effective donor recipient matching by adding haplotyping.